Medigen Vaccine Biologics Corp. is partnering with an American biotech company to develop a COVID-19 vaccine patch, which could begin human clinical trials as early as in 2022, the Taiwanese vaccine maker announced Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Taiwan regrets over no invitation to Nagasaki atomic bomb memorial
05/20/2025 02:36 PM - Politics
Full text of President Lai's address on 1st anniversary of taking office
05/20/2025 01:26 PM - Politics
President Lai highlights sense of threat in 1st foreign TV interview
05/20/2025 01:21 PM - Politics
Taiwan left out of WHA for 9th straight year after ally proposal fails
05/20/2025 12:59 PM - Society
CWA issues high temperature alert for southern, eastern Taiwan areas
05/20/2025 12:32 PM